Aggressive Cutaneous NK and NK-like T-Cell Lymphomas
- 1 May 1999
- journal article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 23 (5) , 571-581
- https://doi.org/10.1097/00000478-199905000-00012
Abstract
Natural killer (NK) and NK-like T-cell lymphomas are rare hematolymphoid malignancies that predominate in the upper aerodigestive system. They also involve other extranodal sites, including the skin. Primary cutaneous manifestations of NK and NK-like T-cell lymphomas are uncommon, and the clinicopathologic features are poorly understood. We have studied 12 patients of varied ethnic backgrounds with CD56-positive lymphomas in the skin. Six patients subsequently progressed to disseminated disease. These lymphomas showed the following immunophenotype: CD56+, CD43+, TCRb-, CD3-/+, CD20-, CD30-/+, CD4-, and CD8-. Two cases exhibited T-cell receptor gene rearrangements supporting a T-cell origin for these lymphomas, whereas the remaining 10 cases were likely derived from NK cells. Our results show inconsistent association of these lymphomas with Epstein-Barr virus (EBV), the multidrug resistance phenotype, and expression of P53. In addition, we found a previously unreported correlation between lymphomas harboring EBV mRNA and the expression of the multidrug resistance phenotype. These lymphomas were aggressive and were associated with rapid clinical progression, treatment failure, multiple relapses, and an average survival of 15 months from the time of diagnosis. Our results indicate the importance of recognizing this disease as a distinct subset of aggressive cutaneous lymphomas that may be diagnosed on the basis of morphology, immunophenotype, and gene rearrangement studies.Keywords
This publication has 36 references indexed in Scilit:
- Lonely No More: p53 Finds Its Kin in a Tumor Suppressor HavenCell, 1997
- THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIESBritish Journal of Haematology, 1997
- Epstein‐Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritisArthritis & Rheumatism, 1996
- Analysis of p53 and mdm‐2 expression in 18 patients with Sézary syndromeBritish Journal of Haematology, 1996
- Inconsistent association of Epstein‐Barr virus with CD56 (NCAM)‐positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tractHistopathology, 1996
- Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell LymphomasThe American Journal of Surgical Pathology, 1996
- Clinicopathologic Study of CD56 (NCAM)-Positive Angiocentric Lymphoma Occurring in Sites Other than the Upper and Lower Respiratory TractThe American Journal of Surgical Pathology, 1995
- Immunohistochemical detection of p53 and bcl‐2 proteins in non‐Hodgkin's lymphomaHistopathology, 1993
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- Angiocentric T-Cell Lymphoma of the SkinThe American Journal of Surgical Pathology, 1988